Gregory Oakes

Insider Reports History

Location
Brooklyn, NY
Signature
/s/ Eric W. Blanchard, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Oakes:

Company Role Class Num Shares Value Price $ Report Date Ownership
Landos Biopharma, Inc. Chief Executive Officer, Director Restricted Stock Unit 0 $0 $0.6900 23 May 2024 Direct
First Wave BioPharma, Inc. Director Stock option (right to buy) 34,482 03 Jan 2022 Direct
Landos Biopharma, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 0 23 May 2024 Direct

Insider Reports Filed by Gregory Oakes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588924014334-oakes-gregory-2024-05-23 Landos Biopharma, Inc. 23 May 2024 3 $0 4 Chief Executive Officer, Director 23 May 2024, 17:45
/report/000120919124004208-oakes-gregory-2024-02-29 Landos Biopharma, Inc. 29 Feb 2024 1 $0 4 Chief Executive Officer, Director 04 Mar 2024, 16:06
/report/000120919123014626-oakes-gregory-2023-02-28 Landos Biopharma, Inc. 28 Feb 2023 1 $0 4 Chief Executive Officer, Director 02 Mar 2023, 15:13
/report/000120919122038682-oakes-gregory-2022-06-20 Landos Biopharma, Inc. 20 Jun 2022 1 $0 4 Chief Executive Officer, Director 22 Jun 2022, 16:28
/report/000120919122038681-oakes-gregory-2022-06-20 Landos Biopharma, Inc. 20 Jun 2022 0 $0 3 Chief Executive Officer, Director 22 Jun 2022, 16:27
ENTO First Wave BioPharma, Inc. 03 Jan 2022 1 $0 4 Director 03 Jan 2022, 20:07